JP4547197B2 - 癌特異的腫瘍抗原 - Google Patents

癌特異的腫瘍抗原 Download PDF

Info

Publication number
JP4547197B2
JP4547197B2 JP2004194599A JP2004194599A JP4547197B2 JP 4547197 B2 JP4547197 B2 JP 4547197B2 JP 2004194599 A JP2004194599 A JP 2004194599A JP 2004194599 A JP2004194599 A JP 2004194599A JP 4547197 B2 JP4547197 B2 JP 4547197B2
Authority
JP
Japan
Prior art keywords
hla
cytotoxic
cells
peptide
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004194599A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006014637A5 (enExample
JP2006014637A (ja
Inventor
公正 安元
光広 竹之山
将一 菅谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2004194599A priority Critical patent/JP4547197B2/ja
Publication of JP2006014637A publication Critical patent/JP2006014637A/ja
Publication of JP2006014637A5 publication Critical patent/JP2006014637A5/ja
Application granted granted Critical
Publication of JP4547197B2 publication Critical patent/JP4547197B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2004194599A 2004-06-30 2004-06-30 癌特異的腫瘍抗原 Expired - Fee Related JP4547197B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004194599A JP4547197B2 (ja) 2004-06-30 2004-06-30 癌特異的腫瘍抗原

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004194599A JP4547197B2 (ja) 2004-06-30 2004-06-30 癌特異的腫瘍抗原

Publications (3)

Publication Number Publication Date
JP2006014637A JP2006014637A (ja) 2006-01-19
JP2006014637A5 JP2006014637A5 (enExample) 2007-08-09
JP4547197B2 true JP4547197B2 (ja) 2010-09-22

Family

ID=35789422

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004194599A Expired - Fee Related JP4547197B2 (ja) 2004-06-30 2004-06-30 癌特異的腫瘍抗原

Country Status (1)

Country Link
JP (1) JP4547197B2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200932260A (en) * 2007-11-28 2009-08-01 Oncotherapy Science Inc STAT3 epitope peptides
TW201000119A (en) * 2008-06-10 2010-01-01 Oncotherapy Science Inc MYBL2 epitope peptides and vaccines containing the same
HUE035804T2 (en) * 2008-07-10 2018-05-28 Toray Industries Immunity inducing agent and method for detecting cancer
HUE028589T2 (en) 2008-07-10 2016-12-28 Toray Industries Pharmaceutical preparation for the treatment and prevention of cancer
JP6077641B2 (ja) 2013-03-08 2017-02-08 大鵬薬品工業株式会社 新規ｃｔｌエピトープ５連結ペプチド
AU2014337643B2 (en) 2013-10-21 2017-07-13 Taiho Pharmaceutical Co., Ltd. Novel four-CTL epitope-joined peptide

Also Published As

Publication number Publication date
JP2006014637A (ja) 2006-01-19

Similar Documents

Publication Publication Date Title
ES2836273T3 (es) Método para el tratamiento del cáncer
JP5182770B2 (ja) Ｍｈｃ分子を結合する腫瘍関連ペプチド
EP3126381B2 (en) Claudin-6-specific immunoreceptors and t cell epitopes
AU749544B2 (en) Tumor antigen peptides originating in cyclophilin B
CN107921111B (zh) 用于各种癌症免疫治疗的新型肽、肽组合物和支架
WO2020154617A1 (en) Compositions and methods for targeting mutant ras
KR20230004914A (ko) 비소세포 폐암 및 기타 암에 대한 면역요법에 사용하기 위한 펩티드 및 펩티드의 조합
JP2017531640A (ja) がん特異的突然変異に対し抗原特異性を有するｔ細胞受容体を単離する方法
EP2971045A2 (en) Compositions and methods for use of recombinant t cell receptors for direct recognition of tumor antigen
CN102971003A (zh) 基于细胞周期素d1衍生的肿瘤相关抗原的癌症改进疗法
IL292864A (en) Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
KR101757798B1 (ko) 면역 유도제
KR20240023426A (ko) 항원-특이적 t 세포를 생산하는 방법
JP4547197B2 (ja) 癌特異的腫瘍抗原
JP4779067B2 (ja) ＨＬＡ−Ａ２４０２拘束性Ｅｐ−ＣＡＭ特異的ＣＴＬが認識するエピトープ・ペプチド及びその用途
Ohshita et al. Generation of tumor-reactive effector lymphocytes using tumor RNA-introduced dendritic cells in gastric cancer patients
Yamasaki et al. Presentation of synthetic peptide antigen encoded by the MAGE-1 gene by granulocyte/macrophage-colony-stimulating-factor-cultured macrophages from HLA-A1 melanoma patients
Fukui et al. Anti-tumor activity of dendritic cells transfected with mRNA for receptor for hyaluronan-mediated motility is mediated by CD4+ T cells
CN113631172B (zh) 用于靶向突变型ras的组合物和方法
Bhaduri T-Cell Receptor-Engineered T (TCR-T) Cell Therapy: Advancements, Challenges
HK40026429B (en) Claudin-6-specific immunoreceptors and t cell epitopes
EP3437652A1 (en) Immunity-inducing agent
HK40011474A (en) Claudin-6-specific immunoreceptors and t cell epitopes
HK40011474B (en) Claudin-6-specific immunoreceptors and t cell epitopes
HK1246802B (en) Claudin-6-specific immunoreceptors and t cell epitopes

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070625

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070625

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100330

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100528

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100615

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100705

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130709

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees